Author Archives: Scalper1

Intra-Cellular Schizophrenia Drug Drives Up Stock

Biotech Intra-Cellular Therapies (ITCI) soared as much as 84% Wednesday after the company announced positive late-stage trial results for its schizophrenia drug. Intra-Cellular said its phase-three study of 450 schizophrenics met the primary endpoint of showing a significant improvement in symptoms among patients taking its drug ITI-007 compared with the placebo group, after four weeks of treatment. The 40 mg dose did not achieve statistical

Apple Royalty King ARM Invests In Internet Of Things

ARM Holdings (ARMH) stock was flat Wednesday morning after the chip company on Tuesday announced investments that could drive $40 million in 2016 revenue but put a 50-cent damper on earnings. The announcement came during ARM’s 2015 investor and analyst day. Pacific Crest analyst Michael McConnell boosted his price target on ARM stock to 64 from 61 and reiterated his buy rating, saying the investments could add 3 cents to EPS ex items by 2017 and